It is however worth noting that, contrary to previous reports that the risk of thrombosis in ALL occur in the induction phase of treatment, although the activity of the natural anticoagulants (ATIII, PC, PS) was lowest in the induction phase, it was low to a comparable extent in the consolidation phase as well. The gene discussed is SERPINC1; the disease is acute lymphoblastic leukemia.